The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice

Anna U Odland1, Jesper L Kristensen, Jesper T Andreasen

  • 1Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Behavioural Pharmacology
|February 17, 2021
PubMed
Summary

The psychedelic drug 25CN-NBOH, a 5-hydroxytryptamine 2A receptor (5-HT2AR) agonist, did not impact cognitive flexibility in mice. This study found no effects on reversal learning, a measure of cognitive flexibility.